Skip to content
Search

Latest Stories

Former head of Kolkata Medical College arrested for graft

Sandip Ghosh was arrested on Monday (2) on charges of financial irregularities

Former head of Kolkata Medical College arrested for graft
Sandip Ghosh being taken to Alipore Judges District and Session Court in Kolkata. (ANI Photo)

INDIA's Central Bureau of Investigation (CBI) has arrested Dr Sandip Ghosh, the former principal of RG Kar Medical College in Kolkata, over allegations of financial misconduct.

His arrest comes amid an ongoing investigation into the rape and murder of a young female doctor at the college. Ghosh resigned from his position shortly after the incident gained public attention.


Alongside Ghosh, three others—two vendors of hospital supplies, Biplav Singha and Suman Hazra, and a close associate, Afsar Ali Khan—were also taken into custody.

A court in Kolkata has placed all four in CBI custody for eight days while investigations continue. The court rejected a bail plea for Khan, while the others did not apply for bail.

The case has drawn widespread attention, not just for the brutal crime committed against the doctor, but also for the corruption allegations surrounding the hospital.

It has been reported that Afsar Ali Khan, who served as a bodyguard for Ghosh, was involved in corrupt activities, such as selling biomedical waste from the hospital. A former deputy superintendent of the college, Akhtar Ali, had previously accused the group of widespread corruption.

The CBI has charged the accused with several offences, including criminal conspiracy and cheating, under the Prevention of Corruption Act. These charges are serious and non-bailable.

The CBI took over the investigation from the Kolkata Police after an order from the Calcutta High Court, directing a thorough probe into the financial misconduct at the institution.

Dr Ghosh, who served as the principal from February 2021, faced criticism after the tragic death of the trainee doctor. Following the incident, the Indian Medical Association suspended his membership, citing serious concerns over the case.

The situation has raised alarm about the safety of women in workplaces across India, echoing concerns that continue to surface despite stricter laws introduced after past incidents of sexual violence.

(with inputs from Reuters)

More For You

Vishal Furia on redefining Indian scares: 'I chose horror because it felt underserved'

Vishal Furia

Vishal Furia on redefining Indian scares: 'I chose horror because it felt underserved'

RISING filmmaking star Vishal Furia is making a name for himself as a master of the horror genre.

The writer-director introduced himself with Lapachhapi (2017), described as the best Marathi horror film ever made. He followed it up with the 2021 scary movies Chhorii and Bali. Furia has added to his impressive list of horror films with newly released sequel Chhorii 2, which is available now on Amazon Prime. Nushrratt Bharuccha and Soha Ali Khan headline the spooky story filled with strange happenings, scares and surprises.

Keep ReadingShow less
Streeting pledges ‘future stability’
for pharmacy with £3.1bn funding
Wes Streeting delivered a video message
Wes Streeting delivered a video message

Streeting pledges ‘future stability’ for pharmacy with £3.1bn funding

HEALTH SECRETARY Wes Streeting said the new £3.1 billion funding package for community pharmacy was a “vital step forward” for the profession as it emerges from a decade of underinvestment and financial strain.

His remarks came at the annual Pharmacy Business Conference last week, attended by more than 240 delegates, including industry leaders who shared valuable insights on funding, independent prescribing, and the role of AI in community pharmacy.

Keep ReadingShow less
Blackburn with Darwen vows to tackle mental health taboos among Asians

Efforts are being made to improve mental health service uptake among Asians

Blackburn with Darwen vows to tackle mental health taboos among Asians

BLACKBURN with Darwen will spend an additional £1.17 million over the next five years on tackling mental health in the borough, with an emphasis on reaching young people and residents of south Asian heritage, writes Bill Jacobs.

The worse than national average figures were set out in a report to senior councillors. Council leader Phil Riley told the meeting last Thursday (10) that figures in the survey, especially for young people, were shocking.

Keep ReadingShow less
Patralekhaa on bringing Savitribai Phule to life in a powerful new biopic

Patralekhaa

Patralekhaa on bringing Savitribai Phule to life in a powerful new biopic

FROM her striking debut in CityLights to diverse and unconventional roles, Patralekhaa has carved a unique path as an actress across film and TV.

Unafraid of challenges, she has continually pushed herself as a performer with characters that demand depth, nuance and emotional honesty. She is also one half of a cinema power couple with her actor husband Rajkummar Rao, and both have motivated one another to cross creative horizons. The acclaimed actress adds to that diverse body of work with the new Bollywood biopic Phule, due to be released next Friday (25). She steps into the shoes of one of India’s greatest social reformers, Savitribai Phule, an experience she describes as both humbling and transformative. The important chapter of 19th-century history sees her portray India’s first female teacher, who, along with her husband Jyotiba Phule, played a vital role in improving women’s rights across the country.

Keep ReadingShow less
UK races to finalise trade deals with India and US amid Trump’s tariff turmoil

Nirmala Sitharaman with Rachel Reeves during her visit to London last Wednesday (9)

UK races to finalise trade deals with India and US amid Trump’s tariff turmoil

BRITAIN is eyeing imminent trade deals with India and the US as uncertainty over American president Donald Trump’s trade policies and his constant back-and-forth on tariffs continues to cast a cloud over markets and the global economic outlook.

Some stability has returned to markets after last week’s rollercoaster ride over Trump’s stop-start tariff announcements, but speculation over new levies on highend technology and pharmaceuticals has kept investors on edge.

Keep ReadingShow less